StemCyte International, Ltd. (TPEX:4178)
Taiwan · Delayed Price · Currency is TWD 24.50
-0.70 (-2.78%)
At close: Sep 19, 2025
StemCyte International Company Description
StemCyte International, Ltd. operates cord blood cell banks in the United States and Taiwan.
It supplies cord blood to medical centers for transplantation in the treatment of blood system diseases; and provides cord blood supply, mononuclear cell supply, and immune cell supply services.
The company also develops cord blood to treat COVID-19 syndrome and acute ischemic stroke; and CB201, an immune cell drug.
In addition, it offers cord blood storage, immune cell storage, and cord blood cell bank transplant cell services.
The company was founded in 2013 and is based in Taipei, Taiwan.
StemCyte International, Ltd.
| Country | Cayman Islands |
| Founded | 2013 |
| Industry | Miscellaneous Health And Allied Services, Not Elsewhere Classified |
Contact Details
Address: No. 508, Zhongxiao E. Rd. Taipei, 115 Taiwan | |
| Phone | 886 2 2601 3013 |
| Website | stemcytebio.com |
Stock Details
| Ticker Symbol | 4178 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 8090 |